Long-lasting insecticidal nets retain bio-efficacy after 5 years of storage: implications for malaria control programmes by Musa, Jeremiah J. et al.
Musa et al. Malar J          (2020) 19:110  
https://doi.org/10.1186/s12936-020-03183-y
RESEARCH
Long-lasting insecticidal nets retain 
bio-efficacy after 5 years of storage: implications 
for malaria control programmes
Jeremiah J. Musa1,2*, Sarah J. Moore1,3,4, Jason Moore1,4, Emmanuel Mbuba1,3,4, Edgar Mbeyela1, Dickson Kobe1, 
Johnson K. Swai1 and Olukayode G. Odufuwa1
Abstract 
Background: Long-lasting insecticidal nets (LLINs) are the most sustainable and effective malaria control tool cur-
rently available. Global targets are for 80% of the population living in malaria endemic areas to have access to (own) 
and use a LLIN. However, current access to LLINs in endemic areas is 56% due to system inefficiencies and budget 
limitations. Thus, cost-effective approaches to maximize access to effective LLINs in endemic areas are required. This 
study evaluated whether LLINs that had been stored for 5 years under manufacturer’s recommended conditions may 
be optimally effective against Anopheles mosquitoes, to inform malaria control programmes and governments on the 
periods over which LLINs may be stored between distributions, in an effort to maximize use of available LLINs.
Methods: Standard World Health Organization (WHO) bioassays (cone and tunnel test) were used to evaluate the 
bio-efficacy and wash resistance of  Olyset® and  DawaPlus® 2.0 (rebranded  Tsara® Soft) LLINs after 5 years of storage 
at 25 °C to 33.4 °C and 40% to 100% relative humidity. In addition, a small scale Ifakara Ambient Chamber test (I-ACT) 
was conducted to compare the bio-efficacy of one long stored LLINs to one new LLIN of the same brand, washed 
or unwashed. LLINs were evaluated using laboratory reared fully susceptible Anopheles gambiae sensu stricto (s.s.) 
(Ifakara strain) and pyrethroid resistant Anopheles arabiensis (Kingani strain).
Results: After 5 years of storage, both unwashed and washed,  Olyset® and  DawaPlus® 2.0  (Tsara® Soft) LLINs passed 
WHO bio-efficacy criteria on knockdown (KD60) ≥ 95%, 24-h mortality ≥ 80% and ≥ 90% blood-feeding inhibition in 
WHO assays against susceptible An. gambiae s.s.  DawaPlus® 2.0 LLINs also passed combined WHO bioassay crite-
ria against resistant An. arabiensis. Confirmatory I-ACT tests using whole nets demonstrated that long-stored LLINs 
showed higher efficacy than new LLINs on both feeding inhibition and mortality endpoints against resistant strains.
Conclusions: Even after long-term storage of around 5 years, both  Olyset® and  DawaPlus® 2.0 LLINs remain effica-
cious against susceptible Anopheles mosquitoes at optimal storage range of 25 °C to 33.4 °C for temperature and 40% 
to 100% relative humidity measured by standard WHO methods.  DawaPlus® 2.0  (Tsara® Soft) remained efficacious 
against resistant strain.
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Background
Long-lasting insecticidal nets (LLINs) remain the most 
sustainable and effective malaria control tool available in 
endemic countries [1], despite insecticide resistance [2]. 
Approximately 663 million cases of malaria have been 
prevented by LLINs since the year 2000, representing 
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68% of the total cases averted by all interventions used 
for malaria control [3]. In 2007, the mass distribution of 
LLINs was recommended by the World Health Organi-
zation (WHO) as the core element of the global malaria 
strategy for malaria vector control in endemic areas [4, 
5]. Between 2008 and 2016, more than 1  billion LLINs 
were distributed in Africa through mass campaigns [6]. 
The wide scale-up of LLIN distribution has led to a sig-
nificant reduction of malaria morbidity and mortality 
[7]. Although, before a brand of LLIN can be listed as 
a potential product for mass campaign by the WHO, it 
must have undergone rigorous laboratory and field test-
ing [8]. Currently, there are 20 brands of LLINs that are 
prequalified by the WHO for use in national distribution 
campaigns [9]. These LLINs are expected to retain their 
insecticidal activity by killing mosquitoes and preventing 
mosquito bites to confer both personal and community 
protection from malaria for at least 3 years (20 washes is 
used as a proxy for 3 years of use) [8].
The public health benefit of LLINs is attained through 
sustained high net access at the community level, which 
is referred to as universal coverage [10]. Currently, the 
global recommended target for population access to 
LLINs is > 80%, and is referred to as the minimum oper-
ational effectiveness coverage level that will translate to 
the community effect of LLINs [11]. Operationally, this is 
defined as one net used per two people (de facto) in the 
population [12, 13].
The governments of malaria endemic countries and 
international donors such as Global Fund, U.S. Presi-
dent’s Malaria Initiative (PMI) as well as non-govern-
mental organisations (NGOs) have been providing funds 
for procurement of LLINs and related logistics to ensure 
high access to LLINs through multiple channels [14, 
15]. Nevertheless, access to LLINs was 56% in endemic 
regions [16]. Even shortly after mass distribution cam-
paigns of LLINs, population access rarely exceeds 80% [6, 
12, 17]. In Tanzania, access to LLINs was 50% [16] and 
trends in malaria burden declines in years after mass 
campaigns and then increases in the following years as 
LLINs wear out. Insufficient access to LLINs is mainly 
due to long intervals between net distribution cam-
paigns, population growth, inadequate funds and budget 
limitations on malaria control programmes [5, 16–18]. 
Increasing access to LLINs through cost-effective solu-
tions remains a critical concern and a number of strate-
gies are being explored for “keep-up campaigns” to retain 
high LLIN access [13].
It is known that the correct storage of LLINs is impor-
tant to retain their bio-efficacy, before and during mass 
distribution campaigns. Exposure of LLINs to direct 
sunlight [19] and storage at high temperature degrade 
the pyrethroid insecticides used on LLINs [19, 20]. Even 
though guidance on the correct storage conditions for 
LLINs before and during distributions is available [21], 
there is limited information on the maximum storage 
period for LLINs before they are no longer bio-effica-
cious. Therefore, this study evaluated the bio-efficacy and 
wash resistance of  Olyset® and  DawaPlus® 2.0 (currently 
rebranded  Tsara® soft) LLINs that have been stored for 
more than 5  years (long storage LLINs) under optimal 
conditions of 25  °C to 33  °C and 40% to 100% relative 
humidity (RH).
Methods
Study design
Two brands of LLINs:  Olyset® and  DawaPlus® 2.0 
 (Tsara® soft) that were stored for more than 5  years 
under recommended conditions were evaluated. The 
study was conducted in two stages. First, through a rand-
omized double blinded, bio-efficacy evaluation of LLINs 
using standard WHO assays [8]. This was followed by 
partially randomized double blinded semi-field tests to 
compare the bio-efficacy of long stored LLINs against the 
new LLINs of the same brand using the Ifakara Ambient 
Chamber tests (I-ACT) [22]. Untreated Safi Net was used 
as a negative control in all tests to monitor the quality of 
the experiment.
Test facility
The experiments were performed at the Vector Control 
Product Testing Unit (VCPTU) of the Ifakara Health 
Institute located in Bagamoyo, Tanzania. (http://ihi.or.tz/
stati c/media /Vecto r-Contr ol-Produ ct-Testi ng.e31c1 73f.
pdf ).
Test nets
Olyset® is a high-density mono-filament polyethylene 
LLIN, incorporated with 20  g/kg (± 3  g/kg), 2% w/w of 
permethrin (corresponding to 1000  mg/m2).  Olyset® is 
manufactured by A to Z Textile Mills Ltd, Arusha, Tanza-
nia. Tsara soft formally known as  DawaPlus® 2.0 is man-
ufactured by NRS Moon Netting FZE [9].  Tsara® soft is 
a deltamethrin-coated LLIN. The target dose of deltame-
thrin coated on a knitted multi-filament polyester fiber 
is 2.0  g/kg ± 25% with 100-denier yarn (corresponding 
to 80  mg/m2 deltamethrin). Untreated Safi Net is made 
of polyester fibres, manufactured by A to Z Textile Mills 
Ltd, Arusha, Tanzania. All nets were double sized and 
coded by an independent IHI staff, to allow blinding of 
investigators and participants. All test nets have WHO-
PQ listing [9].
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Net storage conditions
Olyset® and  DawaPlus® 2.0 LLINs were stored for 
approximately 5  years in the Ifakara Health Institute 
(IHI-Bagamoyo) storage facility and are denoted in this 
study as long storage (LS) nets. All nets were received 
directly under similar conditions from the manufacturer 
and were manufactured shortly before shipping for the 
purpose of product evaluation. LS  Olyset® LLINs with 
batch number L2605 were manufactured in May, 2013 
and logged into the IHI-Bagamoyo storage facility on 
4th June, 2013. LS  DawaPlus® 2.0 LLINs were regular 
production manufactured in November, 2013 and were 
logged into the IHI-Bagamoyo storage facility on 4th 
December, 2013.
The new  Olyset® LLINs were manufactured in 2017 
with Batch number 7X15BZS, and were logged into the 
IHI-Bagamoyo storage facility on 22nd December, 2018. 
The new  DawaPlus® 2.0 LLINs were test series manu-
factured in March, 2018, with batch number 18SPL005, 
were shipped from the manufacturer on 15th May, 2018 
and logged into the IHI-Bagamoyo storage facility on 
1st June, 2018. All nets were stored and maintained at 
an average temperature of 29  °C [25  °C to 33.4  °C] and 
40% to 100% relative humidity (RH) in the IHI-Bagamoyo 
storage facility. Temperature was recorded and logged 
each afternoon at 14:00  h which coincides with peak 
temperatures.
IHI‑Bagamoyo LLINs storage facility
The LLIN storage used in this study was a shipping con-
tainer that uses only passive cooling for the majority of 
the year. The container is raised above the ground and is 
situated under a second shade roof to reduce the radi-
ant transfer of heat. It is installed with aluminium heat 
reflecting foil between the rafter and iron sheet of the 
storage for efficient cooling, also equipped with ventila-
tion gaps (similar to the eaves of African houses) to allow 
air movement through the store. Electric ceiling fans are 
used only at the hottest times of the year irrespective of 
the temperature (Fig. 1).
The experiments were conducted from 25th January 
2019 to July 2019.  Olyset® LLINs had been stored for 
5  years and 2  months while  DawaPlus® 2.0 LLINs had 
been stored for 4 years and 8 months at the time of WHO 
cone assays and tunnel testing.  Olyset® LLINs had been 
stored for 5  years and 8  months while  DawaPlus® 2.0 
LLINs had been stored for 5 years and 2 months at the 
time of I-ACT testing.
LLINs preparation and washing procedures for WHO assays
Eight LLINs (four nets of each brand) were randomly 
selected from the same product batch. LLINs were coded, 
cut into pieces (25 cm × 25 cm) and washed one, three, 
five, ten, 15 and 20 times following WHO standard pro-
cedures for laboratory testing (phase I) [8] The washing 
Fig. 1 The Bagamoyo IHI LLIN storage facility
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interval of 1 day was used based on the reported regen-
eration time for both products [23].
LLINs preparation and washing procedures for I‑ACT assays
Eight LLINs (two old and two new  DawaPlus® 2.0; and 
two old and two new  Olyset®) and two untreated nets 
were randomly selected from their product batches and 
coded. Two LLINs of each brand were washed 20 times 
as per WHO small-scale field trials (field wash) wash-
ing procedures, used as a standard procedure to simu-
late aging of nets under user conditions [8], while the 
other two were unwashed. All washed, unwashed and 
un-treated nets were deliberately holed (4  cm by 4  cm) 
six times, with one hole on each width and two holes on 
each length side, 75  cm from the top of the net as per 
WHO procedures [8].
Test systems
Mosquitoes used for the evaluations were Anopheles 
gambiae sensu stricto (s.s.) (Ifakara strain) fully suscep-
tible to all classes of insecticides and Anopheles arabien-
sis (Kingani strain) strongly resistant to all pyrethroids 
including, deltamethrin and permethrin (< 20% mor-
tality with WHO discriminating doses, through meta-
bolic P450 mechanism). In the WHO cone bioassays, 
nulliparous 3–5  days old female sugar-fed mosquitoes 
were used while in the tunnel test and I-ACT, nullipa-
rous 5–8  days old female mosquitoes’ sugar-starved for 
8 h were used. The VCPTU mosquito colonies are main-
tained at 27 °C ± 5 °C and 40% to 100% relative humidity 
with access to 10% sucrose ad  libitum supplemented by 
membrane feeding using cow blood for the purposes of 
egg production following MR4 guidelines [24].
WHO assays
Cone bioassays were conducted on unwashed and 
“field-washed” long storage LLINs, with four LLINs of 
each brand tested per condition. Five mosquitoes were 
exposed for 3 min per cone on each net replicate. Long 
storage LLINs that failed to meet WHO cone bioassay 
threshold criteria (Table 1), were subjected to WHO tun-
nel test as per WHO guideline [8].
I‑ACT assays
The I-ACT was used as an intermediate between labo-
ratory and experimental hut tests [22]. One LLIN per 
condition (unwashed or washed 20 times) was tested as 
a confirmation of the WHO laboratory bioassay find-
ings. Each LLIN or control was randomly assigned to 
one of the ten testing chambers of the I-ACT (Fig.  2). 
At 21:00  h, volunteer-sleepers released thirty An. gam-
biae and thirty An. arabiensis, in each testing chamber. 
Mosquitoes were lightly dusted with fluorescent powder 
(SWADA, Cheshire, United Kingdom) to distinguish 
the strain as they are morphologically identical. At 06:00 
AM, mosquitoes were collected into paper cups using a 
mouth aspirator. Mosquitoes were scored immediately 
after collection by strain and sorted into four categories: 
(1) dead blood-unfed, (2) dead blood-fed, (3) alive blood-
unfed and (4) alive blood-fed. Mosquitoes were then held 
in the testing laboratory at 27 °C ± 5 °C and 40% to 100% 
relative humidity with access to 10% sugar solution. After 
Table 1 The summary of experimental design on WHO and I-ACT bioassays
Particular WHO cone test WHO tunnel test Ifakara Ambient Chamber test (I‑ACT)
Mosquitoes exposed 80 per net 100 per net piece 60 (30 per strain) per net
Exposure time 3 min 12 h 9 h
Mosquito holding conditions 27 °C ± 5 °C
40–100% RH
27 °C ± 5 °C
40–100% RH
27 °C ± 5 °C
40–100% RH
Mosquito status 3–5 day old female, sugar-
fed, nulliparous
5–8 day old female, sugar-
starved, nulliparous
5–8 day old female, sugar-starved, nulliparous
Bait None Rabbit Human
Outcome measures % KD60 (uncoordnated 
movement or unable to 
move or body impaire-
ment  or rapid fall after 
take off by the mosquito 
after one hour (60mins))
% 24-h mortality
% Feeding inhibition
% 24-h mortality
% Feeding inhibition
% 24-h mortality
WHO efficacy criteria ≥ 95% KD60
≥ 80% 24-h mortality
≥ 90% feeding inhibition
≥ 80% 24-h mortality
≥ 90% feeding inhibition
≥ 80% 24-h mortality
Test validity on negative control ≤ 10% mortality ≥ 50% feeding success
≤ 10% mortality
≥ 50% feeding success
≤ 10% mortality
Analysis Descriptive analysis Descriptive analysis Descriptive analysis and binary logistic regression
Page 5 of 12Musa et al. Malar J          (2020) 19:110  
24-h, the proportion of mosquitoes in each of the four 
categories was again scored using the above criteria. Fol-
lowing each night of the experiment, test nets were re-
packed in their respective bags, chambers were cleaned 
and bed sheets were washed to prevent contamination. 
LLINs remained fixed to their respective chambers while 
sleeper volunteers rotated nightly for ten experimental 
nights so that each volunteer tested each net type once. 
This was done to account for difference between human 
attractiveness to mosquitoes that might affect the pro-
portion of mosquitoes blood feeding. Acceptable mortal-
ity was ≤ 10% or ≥ 50% blood-feeding success in control 
[8] (Table 1, Fig. 2).
Data management and analysis
Data were recorded onto paper forms, double entered 
into Microsoft excel 2013 and cleaned prior to analysis. 
Data analysis was performed using STATA 13.1. Descrip-
tive statistics were used for WHO cone and tunnel tests. 
For the I-ACT, both descriptive statistics and binomial 
logistic regression with mixed effects were conducted. The 
outcome measures were 24-h mortality and blood-feeding 
inhibition. Model fit was tested using AIC [25]. For the 
model with mortality as the outcome, the best fitting model 
had treatment and volunteer as fixed effect and day as a 
random effect while best model with feeding success as the 
outcome had treatment as a fixed effect, with both volun-
teer and day as random effects.
Results
WHO assays with susceptible An. gambiae s.s (Ifakara 
strain)
Olyset®
LLINs stored for 5  years and 2  months (long storage, 
LS) fulfilled WHO bio-efficacy criteria up to 20 washes 
based on the combined WHO cone bioassay and tun-
nel test against susceptible An. gambiae s.s. (Table  2). 
LS  Olyset® LLIN, demonstrated 95% KD60 up to 10 
washes in cone bioassay (Fig.  3a) and > 90% feeding 
inhibition up to 20 washes in tunnel tests (Fig.  3d). 
Mortality was low in cone bioassays (Fig. 3b). 
Fig. 2 I-ACT assay. a Schematic diagram of the Ifakara Ambient Chamber Test (I-ACT with ten chambers); b I-ACT at IHI Bagamoyo branch; c sleeper 
releasing mosquitoes within chamber outside the net; d volunteer (sleeper) sleeping in side net within a chamber; e sleeper collecting mosquitoes 
using mouth aspirator (siphon) inside net within chamber; f sleeper collecting mosquitoes using siphon outside net within chamber
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DawaPlus® 2.0
LLINs stored for 4  years and 8  months fulfilled WHO 
bioefficacy criteria up to 20 washes based on cone bio-
assay against susceptible An. gambiae s.s. (Table  2). LS 
 DawaPlus® 2.0 LLIN, demonstrated 100% KD60 up to 
20 washes (Fig.  3a) and > 90% 24-h mortality up to 20 
washes (Fig. 3b).
WHO assays with resistant Anopheles arabiensis (Kingani 
strain)
LS  Olyset®
LLINs did not fulfil WHO efficacy criteria up to 20 
washes in the combined WHO Cone bioassay and tun-
nel test against resistant An. arabiensis (Table  2). LS 
 Olyset® LLIN did not approach the 95% KD60 thresh-
old in cone tests nor > 80% 24-h mortality (Fig.  4a, c). 
In tunnel tests,  Olyset® LLIN did not approach the 90% 
feeding inhibition threshold in all tests, except nets 
washed three and fifteen times demonstrated > 90% 
feeding inhibition (Fig.  4d).  Olyset® did not generate 
80% 24-h mortality up to 20 washes (Fig. 4c) in either 
cone or tunnel tests.
LS  DawaPlus® 2.0
LLINs fulfilled WHO bioefficacy criteria up to 20 
washes based on the combined WHO Cone bioas-
say and tunnel test against resistant An. arabiensis 
(Table 2). LS  DawaPlus® 2.0 LLIN, either demonstrated 
> 95% KD60 (Fig. 4a) in cone bioassay or > 90% feeding 
inhibition (Fig.  4d). It did not demonstrate 80% 24-h 
mortality up to 20 washes (Fig.  4c) in either cone or 
tunnel tests.
Table 2 WHO bio-assays results against susceptible An. gambiae s.s. and resistant An. arabiensis 
N= number of mosquitoes released on each test
Test system Test item Washes Cone test (N = 80) WHO tunnel test (N = 100) Pass/fail WHO 
efficacy criteria 
(2013)%KD60 [95% CI] %24‑h mortality 
[95% CI]
%Feeding 
inhibition 
[95% CI]
%24‑h 
mortality 
[95% CI]
Susceptible
Anopheles gambiae s.s 
(Ifakara strain)
Olyset® 0 100 03.75 [01.47–06.03] – – Pass
1 100 31.64 [29.40–33.89] – – Pass
3 96.25 [95.06–97.44] 01.25 [00.06–02.44] – – Pass
5 93.75 [89.24–98.26] 0 – – Pass
10 93.75 [92.56–94.94] 02.50 [01.12–03.88] – – Pass
15 83.75 [79.68–87.82] 01.25 [00.06–02.44] 100 90.91 Pass
20 75.00 [69.85–80.15] 03.75 [01.47–06.03] 96.00 51.52 Pass
DawaPlus® 2.0 0 100 92.50 [90.12–94.88] – – Pass
1 100 100 – – Pass
3 100 98.75 [97.56–99.94] – – Pass
5 100 97.50 [96.12–98.88] – – Pass
10 100 96.25 [92.68–99.80] – – Pass
15 100 93.75 [87.79–99.71] – – Pass
20 100 100 – – Pass
Resistant
Anopheles arabiensis 
(Kingani strain)
Olyset® 0 38.75 [34.68–42.82] 0 – – –
1 25.00 [19.85–30.15] 01.25 [00.06–2.44] – – –
3 23.75 [19.68–27.82] 03.75 [01.47–6.03] 96.00 09.18 Pass
5 51.25 [47.18–55.32] 03.75 [02.56–4.94] 87.00 12.24 Fail
10 36.25 [33.25–39.25] 01.25 [00.06–2.44] 87.00 14.29 Fail
15 53.75 [40.79–66.71] 0 92.00 19.39 Pass
20 58.75 [57.56–59.94] 0 88.00 22.45 Fail
DawaPlus® 2.0 0 50.00 [44.85–55.15] 10.00 [05.64–14.35] – – –
1 63.75 [61.47–66.03] 11.25 [06.74–15.76] – – –
3 67.50 [63.37–71.63] 16.25 [15.06–17.44] 90.00 61.62 Pass
5 91.25 [87.68–94.82] 36.25 [31.34–41.16] 94.00 56.57 Pass
10 100 23.75 [19.68–27.82] 94.00 78.79 Pass
15 97.50 [96.12–98.88] 05.00 [01.63–08.37] 68.00 51.52 Pass
20 93.75 [89.24–98.26] 12.50 [09.42–15.58] 93.00 41.41 Pass
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I‑ACT results against susceptible An. gambiae s.s. (Ifakara 
strain)
Against susceptible An. gambiae s.s, LS  Olyset® and 
 DawaPlus® 2.0 unwashed and washed 20 times exceeded 
the WHO bio-efficacy criteria for tunnel test on 24-h 
mortality (≥ 80%) and feeding inhibition (≥ 90%). LS 
 Olyset® and LS  DawaPlus® 2.0 nets unwashed and 
washed 20 times performed similar to new nets of the 
same brand and washing status, showing almost identi-
cal measurements of mortality and feeding inhibition 
(Table  3). Washing the nets 20 times only marginally 
reduced their efficacy but still induced high mortality and 
feeding inhibition, with the old nets nearly as efficacious 
as the new nets. On the mortality endpoint, LS unwashed 
 Olyset® marginally outperformed the new unwashed 
 Olyset®: 99.30% [98.25–100] vs 96.28% [93.64–98.93], 
odds ratio 0.17 [0.04–0.79] p = 0.024. On the feeding 
inhibition endpoint, LS  DawaPlus® 2.0 washed 20 times 
marginally outperformed the new  Tsara® Soft washed 20 
times: 95.62% [92.81–98.42] vs 83.81% [78.98–88.64] OR 
4.37 [2.67–7.15], p < 0.0001 (Table 3).
I‑ACT results against resistant An. arabiensis (Kingani)
Against resistant An. arabiensis, unwashed LS  Olyset® 
and unwashed LS  DawaPlus® 2.0 exceeded the WHO 
bio-efficacy criteria for tunnel tests on feeding inhibi-
tion (≥ 90%). All the net types and condition failed to 
meet WHO bioefficacy criteria on 24-h mortality (≥ 80%) 
against the resistant strain.  Olyset® and  DawaPlus® 2.0 
LS nets unwashed and washed 20 times performed in a 
similar way to new nets of the same brand and washing 
status on both endpoints showing almost identical mor-
tality and feeding inhibition (Table  3). As was observed 
with the susceptible strain, on the mortality endpoint, 
LS unwashed  Olyset® marginally outperformed the 
new unwashed  Olyset® 63.40% [47.83–78.97] vs 50.31% 
Fig. 3 WHO bio-assay results against susceptible An. gambiae s.s. (Ifakara strain). a Percentage KD60, b WHO cone assay percentage 24-h mortality. 
c Tunnel test percentage 24-h mortality, d percentage blood-feeding inhibition. In all graphs the dashed line is the WHO cut off criteria, 95% for 
KD60, 80% for mortality, and 90% for blood-feeding inhibition. c, d Do not have 95% CI, since only one sample per condition, that failed in cone 
bioassays was re-tested in WHO Tunnel test as per WHO guideline [8]
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[33.42–67.19], odds ratio 0.49 [95% CI 0.33–0.72], 
p < 0.0001 (Table 3). On the feeding inhibition endpoint, 
LS unwashed  DawaPlus® 2.0 outperformed the new 
unwashed  DawaPlus®: 91.57% [88.72–94.41] vs 81.78% 
[75.49–88.07], OR 2.55 [1.61–4.06], p < 0.0001 (Table 3). 
Additionally, on the feeding inhibition endpoint, LS 
 DawaPlus® 2.0 washed 20 times outperformed the new 
 DawaPlus® 2.0 washed 20 times: 83.28% [76.48–90.08] 
vs 59.87% [49.89–69.85], OR 4.07 [2.60–6.36], p < 0.0001 
(Table 3).
Discussion
This study provides valuable information on the effect 
of long storage conditions on the bio-efficacy of LLINs 
for malaria control programmes. The study showed that 
LLINs remained efficacious despite being stored for 
about 5  years under controlled storage conditions. The 
nets used for this study were pyrethroid of two types: 
 Olyset®, a permethrin incorporated net, and  DawaPlus® 
2.0  (Tsara® soft), a deltamethrin coated net with insecti-
cide held to the filaments using a binder.
It was necessary to keep the investigational LLINs 
under ideal temperature and humidity conditions, as it is 
known that high temperature may inactivate the insecti-
cide or binder [19, 26]. Proper storage should also avoid 
direct sunlight as pyrethroids are decomposed by UV 
light and heat [27]. Several studies have been conducted 
to evaluate the storage conditions of LLINs. For example, 
the study conducted in Turkey by Karakus et al. reported 
that nets exposed to direct sunlight for 6  months, had 
lower efficacy (44.4% 24-h mortality), than other groups 
of nets which were not exposed to sunlight (100% 24-h 
mortality) [19]. Atieli et al. showed that drying methods 
used after washing nets, resulted in significant impact 
on the efficacy of pyrethroid nets: nets washed 20 times 
and dried under the shade retained more pyrethroid 
Fig. 4 WHO bio-assay results against resistant An. arabiensis (Kingani strain). a Percentage KD60, b WHO cone assay percentage 24-h mortality. c 
Tunnel test percentage 24-h mortality. d Percentage blood-feeding inhibition. In all graphs the dashed line is the WHO cut off criteria, 95% for KD60, 
80% for mortality, and 90% for blood-feeding inhibition. c, d Do not have 95% CI, since only one sample per condition that failed in cone bioassays 
was re-tested in WHO Tunnel test as per WHO guideline [8]
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insecticide (62.5%) than nets directly dried under the 
sunlight (58.8%) [20]. Furthermore, Peck et  al. reported 
that the insecticidal activity of the pyrethroid Lambda-
cyhalothrin was reduced after 10  weeks of exposure to 
direct sunlight [26].
LLINs are designed to withstand the high tempera-
tures that may be encountered in the tropics and the 
findings from this study suggest that nets can retain 
bio-efficacy for up to 5  years if stored out of sunlight 
at the range of 25  °C to 33.4  °C and 40% to 100% rela-
tive humidity. The storage conditions used in this study 
aligned with the manufacturer specification and WHO 
guidelines [27, 28]. Therefore, national malaria control 
programmes (NMCPs) and other stakeholders should 
be well informed on the appropriate long-term storage 
conditions for pyrethroid nets in order for the LLINs 
to retain their bio-efficacy, if nets are to be stored for 
extended period before distribution. NMCPs also advised 
to invest on storage facilities that use shading and passive 
heat transfer similar to that of the Ifakara Health Institute 
(Fig. 1) at a low running cost to ensure efficacy of LLINs 
after storage.
The performance of long storage (LS) LLINs varied 
between net brands and washes in the WHO cone bioas-
say.  DawaPlus® 2.0 LLIN, met the WHO criteria in the 
standard WHO cone assay without the need to conduct 
a WHO tunnel test, while  Olyset® LLIN failed to meet 
the criteria based on the cone assay but passed based 
on WHO tunnel test (Table  2). This is because  Olyset® 
is a high density polyethylene net, meaning that migra-
tion of permethrin is very slow with short wash intervals, 
hence surface concentrations are very low, sufficient to 
induce KD60 effect, but insufficient to induce mortality 
[22, 29, 30]. This mode of action reduces the probability 
of mosquito dying from exposure to the insecticide fol-
lowing multiple contacts with net, but also gives  Olyset® 
its feeding inhibition properties that were observed in 
the I-ACT (Table 3), allowing protection of human vol-
unteers sleeping beneath them even after 5  years and 
2  months of storage. Similar results were observed by 
Table 3 I-ACT results against susceptible Anopheles gambiae s.s and resistant An. arabiensis 
N = 30 mosquitoes released per strain per test
LS long storage
a Arithmetic mean control-corrected 24-h mortality with 95% confidence intervals (CI) and Arithmetic mean blood-feeding inhibition with 95% confidence intervals 
(CI)
Test system Test items %24‑h  mortalitya 
[95% CI]
Odds of dying 
[95% CI]
p‑value % feeding 
inhibition [95% CI]
Odds of feeding 
[95% CI]
p‑value
Susceptible 
Anopheles 
gambiae s.s. 
(Ifakara strain)
LS  Olyset® 
unwashed
New  Olyset® 
unwashed
99.30 [98.25–100.0]
96.28 [93.64–98.93]
1.00
0.17 [0.04–0.79]
0.024 94.00 [92.76–99.11]
97.27 [94.84–99.69]
1.00
0.54 [0.05–5.80]
0.610
LS  Olyset® washed
New  Olyset® 
washed
85.73 [76.58–94.86]
85.44 [74.29–96.59]
1.00
1.09 [0.61–1.93]
0.775 91.40 [88.66–94.14]
92.29 [88.73–95.86]
1.00
0.84 [0.35–1.99]
0.693
Old  DawaPlus® 2.0 
unwashed
New  DawaPlus® 2.0 
unwashed
99.66 [98.88–100.0]
99.65 [98.88–100.0]
– – 96.12 [94.40–97.83]
89.37 [82.90–95.84]
1.00
2.14 [0.62–7.47]
0.231
Old  DawaPlus® 2.0 
washed
New  DawaPlus® 2.0 
washed
100
96.94 [95.56–98.32]
– – 95.62 [92.81–98.42]
83.81 [78.98–88.64]
1.00
4.37 [2.67–7.15]
0.0001
Resistant Anoph-
eles arabiensis 
(Kingani 
strain)
Old  Olyset® 
unwashed
New  Olyset® 
unwashed
63.40 [47.83–78.97]
50.31 [33.42–67.19]
1.00
0.49 [0.33–0.72]
0.0001 92.10 [88.24–95.95]
95.16 [91.07–99.26]
1.00
0.37 [0.08–1.76]
0.213
Old  Olyset® washed
New  Olyset® 
washed
33.34 [17.91–48.77]
37.85 [20.11–55.59]
1.00
1.18 [0.81–1.72]
0.401 84.25 [79.51–88.99]
86.88 [80.34–93.43]
1.00
0.67 [0.29–1.51]
0.329
Old  DawaPlus® 2.0 
unwashed
New  DawaPlus® 2.0 
unwashed
71.30 [56.28–86.32]
68.91 [50.64–87.19]
1.00
0.82 [0.53–1.3]
0.364 91.57 [88.72–94.41]
81.78 [75.49–88.07]
1.00
2.55 [1.61–4.06]
0.0001
Old  DawaPlus® 2.0 
washed
New  DawaPlus® 2.0 
washed
48.73 [34.18–63.28]
45.74 [27.90–63.57]
1.00
0.86 [0.60–1.22]
0.393 83.28 [76.48–90.08]
59.87 [49.89–69.85]
1.00
4.07 [2.60–6.36]
0.0001
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Massue et  al. [22]. It was again observed, by Jaramillo 
et  al., on which permethrin treated net  (Olyset® LLIN) 
reduced contacts of Anopheles albimanus to net surface 
in the cone test [31].
Both LS  Olyset® and  DawaPlus® 2.0 performed well 
on the feeding inhibition end point against the resistant 
An. arabiensis (Kingani strain), this is crucial because 
the results suggest that pyrethroid nets may still confer 
blood feeding protection against resistant mosquitoes 
due to irritancy [32]. However, it is clear that LLIN per-
formance was not significantly impaired as a result of 
long storage, but due to ability of the resistant strain to 
detoxify pyrethroids [33–35]. It is for this reason that 
piperonyl butoxide-treated insecticidal nets (PBO) nets 
have been developed [36]. PBO is a synergist commonly 
used in pest control, combined with pyrethroid, that hin-
ders enzymatic detoxification of pyrethroids that enables 
the survival of individuals with upregulated detoxifica-
tion phenotypes, and allow the pyrethroids insecticide 
to finally kills pyrethroid resistant mosquitoes [37]. It 
is planned to conduct further studies to investigate the 
long-term storage stability of nets treated with PBO in 
the future using the set up described here. Although, it 
is interesting that both nets still performed well on the 
feeding inhibition end point, which means that long 
stored pyrethroids LLINs can still confer protection, 
therefore, reiterate the usefulness in the continuous con-
trol of mosquitoes.
Results from the I-ACT with volunteers sleeping 
beneath the LLINs complemented the evidence pro-
vided by the WHO cone assays and allowed for com-
parison between new nets and long storage nets of the 
same brand and washing status. Using WHO pass/
fail thresholds, findings from WHO cone assays and 
the I-ACT with LS nets agreed between net brands and 
washes. Although, using the WHO criteria, both LS nets 
and new nets passed with the susceptible strain but gave 
inconsistent results with the resistant strain. The I-ACT 
demonstrated higher feeding inhibition and mortality 
(Tables 2 and 3). The increased performance of LLINs in 
the I-ACT might be due to extended exposure time that 
increased number of contacts between mosquitoes and 
the LLIN, use of a whole net and the use of a preferred 
(human) bait by mosquito and larger surface are of net 
presented to the mosquitoes. Similar I-ACT results have 
also been observed by Massue et al. [22]. However, find-
ings from current study shown that, long storage nets 
performed similarly to the new nets in the I-ACT on both 
mortality and feeding inhibition endpoints.
Study limitations
The study was conducted as per protocol and WHO 
guidelines for LLIN evaluations. However, the I-ACT 
study was not sufficiently powered (< 80%) and one net 
per condition was used, which limited the study to ade-
quately measure inter-net heterogeneity due to limited 
number of test nets available in the facility. The bursting 
strength of nets and chemical analysis was not evaluated 
and this needs to be considered to understand the effect 
of storage on the fabric strength and amount of insecti-
cides present. Therefore, the findings of the study should 
be cautiously interpreted and we recommend further 
studies to be conducted in multiple sites with sufficient 
power to detect differences between nets for each condi-
tion, and additional evaluations of bursting strength after 
storage.
Conclusion
Even after long-term storage of around 5 years,  Olyset® 
and  DawaPlus® 2.0 (now called  Tsara® soft) LLINs 
remain efficacious against susceptible Anopheles mos-
quitoes at optimal storage range of 25  °C to 33.4  °C for 
temperature and 40% to 100% relative humidity meas-
ured by standard WHO methods.  DawaPlus® 2.0  (Tsara® 
soft) also, passed WHO efficacy criteria on unwashed 
LLINs and after 20 washes against resistant An. arabien-
sis. These data were confirmed in the I-ACT. Therefore, 
long stored nets can still be useful in controlling malaria 
in endemic areas when optimal storage conditions of nets 
is maintained.
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